Compare
Privia Health Group, Inc. vs P3 Health Partners Inc. vs InnovAge Holding Corp. vs Pennant Group, Inc.
| Latest fiscal year | Privia Health Group, Inc. PRVA | P3 Health Partners Inc. PIII | InnovAge Holding Corp. INNV | Pennant Group, Inc. PNTG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | $2.12B | $1.46B | $989.71M | $947.71M |
| Revenue growth (YoY) | +22.3% | -2.8% | +15.9% | +36.3% |
| Gross margin | n/a | n/a | 23.0% | n/a |
| Operating margin | 1.6% | -18.5% | 0.3% | 5.5% |
| Net margin | 1.1% | -10.1% | -0.3% | 3.1% |
| Net income | $22.92M | -$147.95M | -$2.54M | $29.58M |
| EPS (Diluted) | $0.18 | -$45.26 | -$0.02 | $0.84 |
| Operating cash flow | $163.40M | -$91.24M | $64.71M | $48.29M |
| Free cash flow | n/a | n/a | $50.41M | $36.26M |
| Cash & equivalents | $479.69M | $25.01M | $97.89M | n/a |
| Total assets | $1.37B | $656.64M | $557.39M | $968.18M |
| Total liabilities | $578.43M | $796.88M | $288.62M | $593.93M |
| Shareholders' equity | $790.94M | -$155.23M | $235.60M | $374.25M |
| Return on year-end equity | 2.9% | n/a | -1.1% | 7.9% |
| Shares outstanding | 123.60M | n/a | 136.02M | 34.63M |
Revenue, most recent five fiscal years
| Fiscal year | Privia Health Group, Inc. | P3 Health Partners Inc. | InnovAge Holding Corp. | Pennant Group, Inc. |
|---|---|---|---|---|
| Latest | $2.12B Ended 2025-12-31 | $1.46B Ended 2025-12-31 | $989.71M Ended 2026-06-30 | $947.71M Ended 2025-12-31 |
| 1 year earlier | $1.74B Ended 2024-12-31 | $1.50B Ended 2024-12-31 | $853.70M Ended 2025-06-30 | $695.24M Ended 2024-12-31 |
| 2 years earlier | $1.66B Ended 2023-12-31 | $1.27B Ended 2023-12-31 | $763.86M Ended 2024-06-30 | $544.89M Ended 2023-12-31 |
| 3 years earlier | $1.36B Ended 2022-12-31 | $1.05B Ended 2022-12-31 | $688.09M Ended 2023-06-30 | $473.24M Ended 2022-12-31 |
| 4 years earlier | $966.22M Ended 2021-12-31 | n/a | $698.64M Ended 2022-06-30 | $439.69M Ended 2021-12-31 |